High prevalence of pulmonary tuberculosis among female sex workers, men who have sex with men, and transgender women in Papua New Guinea.

Female sex workers HIV Men who have sex with men Transgender women Tuberculosis

Journal

Tropical medicine and health
ISSN: 1348-8945
Titre abrégé: Trop Med Health
Pays: Japan
ID NLM: 101215093

Informations de publication

Date de publication:
13 Jan 2021
Historique:
received: 19 08 2020
accepted: 22 12 2020
entrez: 14 1 2021
pubmed: 15 1 2021
medline: 15 1 2021
Statut: epublish

Résumé

Papua New Guinea (PNG) has a tuberculosis (TB) case notification rate of 333 cases per 100,000 population in 2016 and is one of the 14 countries classified by the World Health Organization (WHO) as "high-burden" for TB, multi-drug-resistant TB (MDR-TB), and TB/HIV. HIV epidemic is mixed with a higher prevalence among key populations, female sex workers (FSW), men who have sex with men (MSM), and transgender women (TGW). We conducted a cross-sectional HIV biobehavioral survey (BBS) using respondent-driven sampling method among FSW, MSM, and TGW in Port Moresby, Lae, and Mt. Hagen (2016-2017). As part of the study, participants were screened for the four symptoms suggestive of TB infection using the WHO TB screening algorithm. Sputum and venous whole blood samples were collected and tested for pulmonary TB and HIV infection, respectively. Pulmonary TB testing was performed using GeneXpert®MTB/RIF molecular point-of-care test, and HIV testing was done following the PNG national HIV testing algorithm. All data discussed are weighted unless otherwise mentioned. Among FSW, 72.6%, 52.0%, and 52.9% in Port Moresby, Lae, and Mt. Hagen, respectively, experienced at least one symptom suggestive of TB infection. Among MSM and TGW, 69% and 52.6% in Port Moresby and Lae, respectively, experienced at least one symptom suggestive of TB infection. Based on GeneXpert®MTB/RIF results, the estimated TB prevalence rate among FSW was 1200, 700, and 200 per 100,000 in Port Moresby, Lae, and Mt. Hagen, respectively. Among MSM and TGW, the estimated TB prevalence rate was 1000 and 1200 per 100,000 in Port Moresby and Lae, respectively. Co-prevalence of TB/HIV among FSW was 0.1% in Port Moresby and 0.2% in Lae. There were no co-prevalent cases among FSW in Mt. Hagen or among MSM and TGW in Port Moresby and Lae. Key populations have a higher estimated rate of pulmonary TB than the national rate of pulmonary and extra-pulmonary TB combined. This showed that screening key populations for TB should be integrated into HIV programs regardless of HIV status in PNG's national TB response.

Sections du résumé

BACKGROUND BACKGROUND
Papua New Guinea (PNG) has a tuberculosis (TB) case notification rate of 333 cases per 100,000 population in 2016 and is one of the 14 countries classified by the World Health Organization (WHO) as "high-burden" for TB, multi-drug-resistant TB (MDR-TB), and TB/HIV. HIV epidemic is mixed with a higher prevalence among key populations, female sex workers (FSW), men who have sex with men (MSM), and transgender women (TGW).
METHODS METHODS
We conducted a cross-sectional HIV biobehavioral survey (BBS) using respondent-driven sampling method among FSW, MSM, and TGW in Port Moresby, Lae, and Mt. Hagen (2016-2017). As part of the study, participants were screened for the four symptoms suggestive of TB infection using the WHO TB screening algorithm. Sputum and venous whole blood samples were collected and tested for pulmonary TB and HIV infection, respectively. Pulmonary TB testing was performed using GeneXpert®MTB/RIF molecular point-of-care test, and HIV testing was done following the PNG national HIV testing algorithm. All data discussed are weighted unless otherwise mentioned.
RESULTS RESULTS
Among FSW, 72.6%, 52.0%, and 52.9% in Port Moresby, Lae, and Mt. Hagen, respectively, experienced at least one symptom suggestive of TB infection. Among MSM and TGW, 69% and 52.6% in Port Moresby and Lae, respectively, experienced at least one symptom suggestive of TB infection. Based on GeneXpert®MTB/RIF results, the estimated TB prevalence rate among FSW was 1200, 700, and 200 per 100,000 in Port Moresby, Lae, and Mt. Hagen, respectively. Among MSM and TGW, the estimated TB prevalence rate was 1000 and 1200 per 100,000 in Port Moresby and Lae, respectively. Co-prevalence of TB/HIV among FSW was 0.1% in Port Moresby and 0.2% in Lae. There were no co-prevalent cases among FSW in Mt. Hagen or among MSM and TGW in Port Moresby and Lae.
CONCLUSIONS CONCLUSIONS
Key populations have a higher estimated rate of pulmonary TB than the national rate of pulmonary and extra-pulmonary TB combined. This showed that screening key populations for TB should be integrated into HIV programs regardless of HIV status in PNG's national TB response.

Identifiants

pubmed: 33441184
doi: 10.1186/s41182-020-00293-w
pii: 10.1186/s41182-020-00293-w
pmc: PMC7805114
doi:

Types de publication

Journal Article

Langues

eng

Pagination

4

Subventions

Organisme : Center for Disease Control and Prevention
ID : 01531GH15

Références

Sociol Methodol. 2011 Aug 1;41(1):355-366
pubmed: 22228916
Rev Soc Bras Med Trop. 2018 May-Jun;51(3):324-330
pubmed: 29972563
PLoS One. 2010 Dec 23;5(12):e15586
pubmed: 21203468
Western Pac Surveill Response J. 2018 Jun 15;9(2):9-19
pubmed: 30057853
J Int AIDS Soc. 2015 Feb 16;18:19317
pubmed: 25690530
Int J Tuberc Lung Dis. 2009 May;13(5):626-32
pubmed: 19383197
Int J Tuberc Lung Dis. 2017 Aug 1;21(8):922-929
pubmed: 28786801
JMIR Public Health Surveill. 2019 Mar 21;5(1):e11285
pubmed: 30896432
Iran Red Crescent Med J. 2013 Sep;15(9):775-9
pubmed: 24616784
AIDS Rev. 2018 Apr-Jun;20(2):114-124
pubmed: 29938705
Int J Tuberc Lung Dis. 2018 May 1;22(5):524-529
pubmed: 29663957
Sex Health. 2020 Aug;17(4):311-320
pubmed: 32698941
Biometrics. 2015 Mar;71(1):258-266
pubmed: 25585794
Epidemiol Infect. 2017 Feb;145(3):498-502
pubmed: 27866487
Ethiop J Health Sci. 2018 May;28(3):347-354
pubmed: 29983535
BMC Public Health. 2019 May 22;19(1):623
pubmed: 31117978

Auteurs

Barne Willie (B)

Papua New Guinea Institute of Medical Research, Goroka, 441 EHP, Papua New Guinea.

Avi J Hakim (AJ)

US Centers for Disease Control and Prevention, Atlanta, USA.

Steven G Badman (SG)

Kirby Institute for Infection and Immunity, UNSW Sydney, Sydney, Australia.

Damian Weikum (D)

US Centers for Disease Control and Prevention, Atlanta, USA.

Rebecca Narokobi (R)

Papua New Guinea Institute of Medical Research, Goroka, 441 EHP, Papua New Guinea.

Kelsey Coy (K)

US Centers for Disease Control and Prevention, Atlanta, USA.

Josephine Gabuzzi (J)

Papua New Guinea Institute of Medical Research, Goroka, 441 EHP, Papua New Guinea.

Simon Pekon (S)

Papua New Guinea Institute of Medical Research, Goroka, 441 EHP, Papua New Guinea.

Samson Gene (S)

Papua New Guinea Institute of Medical Research, Goroka, 441 EHP, Papua New Guinea.

Angelyn Amos (A)

Papua New Guinea Institute of Medical Research, Goroka, 441 EHP, Papua New Guinea.

Martha Kupul (M)

Papua New Guinea Institute of Medical Research, Goroka, 441 EHP, Papua New Guinea.

Parker Hou (P)

Papua New Guinea Institute of Medical Research, Goroka, 441 EHP, Papua New Guinea.

Nick M Dala (NM)

Papua New Guinea National Department of Health, Port Moresby, Papua New Guinea.

David M Whiley (DM)

Centre for Clinical Research, University of Queensland, Brisbane, Australia.

Johanna Wapling (J)

Papua New Guinea Institute of Medical Research, Goroka, 441 EHP, Papua New Guinea.

John M Kaldor (JM)

Kirby Institute for Infection and Immunity, UNSW Sydney, Sydney, Australia.

Andrew J Vallely (AJ)

Papua New Guinea Institute of Medical Research, Goroka, 441 EHP, Papua New Guinea.
Kirby Institute for Infection and Immunity, UNSW Sydney, Sydney, Australia.

Angela Kelly-Hanku (A)

Papua New Guinea Institute of Medical Research, Goroka, 441 EHP, Papua New Guinea. a.kelly@unsw.edu.au.
Kirby Institute for Infection and Immunity, UNSW Sydney, Sydney, Australia. a.kelly@unsw.edu.au.

Classifications MeSH